results
-
Biologics
Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA
In the MAXA trial, standalone MagnetOs outperformed the gold standard autograft by 73% in posterior spinal fusion in a difficult-to-treat…
Read More » -
Biologics
Orthofix Announces Publication in The Spine Journal of Five-Year Data for the M6-C Artificial Cervical Disc
With more than 100,000 implantations worldwide, the M6-C and M6-L discs continue to demonstrate strong clinical performance, safety and patient…
Read More » -
Biologics
Cerapedics Reinforces Commitment to Level 1 Evidence with Long-Term Results from Six-Year Pivotal IDE Cervical Study Demonstrating 98.6% Spine Fusion Rates in Patients Treated With i-FACTOR®
WESTMINSTER, Colo., Oct. 17, 2023 /PRNewswire/ — Cerapedics Inc., a commercial-stage orthopedics company dedicated to redefining the standard of care for bone…
Read More » -
Neuro
Relievant Medsystems Announces Pooled 4-Year Outcomes Validating Long-Term Effectiveness of the Intracept Procedure
Findings, Presented at Annual American Society of Pain & Neuroscience Conference, Demonstrate Significant and Durable Relief of Chronic Vertebrogenic Low…
Read More » -
Spine
Viseon Inc. Announces Preliminary Results of Surgeon Experience Database Utilizing MaxView® System During Minimally Invasive Lateral Spine Surgery
November 30, 2022 IRVINE, Calif.–(BUSINESS WIRE)–Today Viseon Inc. announced preliminary results from the clinical use of the MaxView® intraoperative imaging technology…
Read More » -
Spine
Aurora Spine Corporation Announces Positive Interim Results from Clinical Study using ZIP™ MIS Interspinous Fusion System
Initial results show ZIP device to be effective and safe CARLSBAD, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) — Aurora Spine…
Read More » -
Neuro
Mainstay Medical Announces Publication of Three-Year Patient Outcomes Data from ReActiv8-B Clinical Trial Demonstrating Long-Term Efficacy of ReActiv8® Restorative Neurostimulation™
Data continue to show compelling efficacy and safety, including improvement on all key measures of pain and disability, as compared…
Read More » -
Biologics
Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for StemSpine® Study
–Two-Year Follow-Up Results Confirm Significant Efficacy and No Serious Adverse Effects in Patients who Underwent the StemSpine® Procedure for Treating…
Read More » -
Biologics
Regenexx Publishes Mid-term Results of Its Randomized Controlled Trial Showing Its Perc-ACLR Procedure Can Help Patients Avoid Surgical ACL Reconstruction
DES MOINES, Iowa, Aug. 10, 2022 /PRNewswire/ — Regenexx®, a research-driven interventional orthobiologics network of physicians performing regenerative orthopedic procedures, has published…
Read More »